[
  {
    "ts": "2026-02-04T05:41:56+00:00",
    "headline": "The Top 5 Analyst Questions From Danaher’s Q4 Earnings Call",
    "summary": "Danaher’s fourth quarter results met Wall Street’s revenue expectations, with management attributing performance to ongoing strength in its bioprocessing segment and steady growth in diagnostics. CEO Rainer Blair noted that bioprocessing consumables demand, especially for monoclonal antibodies, remained robust, while diagnostic platforms benefited from an active respiratory season and expanding test menus. However, management acknowledged ongoing softness in academic and government research fund",
    "url": "https://finance.yahoo.com/news/top-5-analyst-questions-danaher-054156627.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "734431a4-b835-3211-8232-440869d7b896",
      "content": {
        "id": "734431a4-b835-3211-8232-440869d7b896",
        "contentType": "STORY",
        "title": "The Top 5 Analyst Questions From Danaher’s Q4 Earnings Call",
        "description": "",
        "summary": "Danaher’s fourth quarter results met Wall Street’s revenue expectations, with management attributing performance to ongoing strength in its bioprocessing segment and steady growth in diagnostics. CEO Rainer Blair noted that bioprocessing consumables demand, especially for monoclonal antibodies, remained robust, while diagnostic platforms benefited from an active respiratory season and expanding test menus. However, management acknowledged ongoing softness in academic and government research fund",
        "pubDate": "2026-02-04T05:41:56Z",
        "displayTime": "2026-02-04T05:41:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/f7c48f94496cc685707bb82fa48852a9",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "DHR Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lQBC7nIOUIxAsi7pN3Mziw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/f7c48f94496cc685707bb82fa48852a9.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NL6F_XQC1SIlNraLaRAr1g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/f7c48f94496cc685707bb82fa48852a9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-5-analyst-questions-danaher-054156627.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-5-analyst-questions-danaher-054156627.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DHR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]